Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 1675-1683, March 15, 2007. doi: 10.1158/1078-0432.CCR-06-2489
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, R. R.
Right arrow Articles by Mehta, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, R. R.
Right arrow Articles by Mehta, M. P.
Related Collections
Right arrow Clinical Research
Right arrow Clinical Research: Clinical Pharmacology
Right arrow Clinical Research: Clinical Trials

CCR Focus

Targeted Therapy for Brain Metastases: Improving the Therapeutic Ratio

Rakesh R. Patel and Minesh P. Mehta

Authors' Affiliation: Department of Human Oncology, University of Wisconsin, Madison, Wisconsin

Requests for reprints: Rakesh R. Patel, Department of Human Oncology, University of Wisconsin, 600 Highland Avenue, K4/B100, Madison, WI 53792. Phone: 608-263-8500; Fax: 608-263-9167; E-mail: patel{at}humonc.wisc.edu.

Abstract

Brain metastasis is the most common intracranial malignancy in adults. Improvements in modern imaging techniques are detecting previously occult brain metastases, and more effective therapies are extending the survival of patients with invasive cancer who have historically died from extracranial disease before developing brain metastasis. This combination of factors along with increased life expectancy has led to the increased diagnosis of brain metastases. Conventional treatment has been whole brain radiotherapy, which can improve symptoms, but potentially results in neurocognitive deficits. Several strategies to improve the therapeutic ratio are currently under investigation to either enhance the radiation effect, thereby preventing tumor recurrence or progression as well as reducing collateral treatment-related brain injury. In this review article, we discuss new directions in the management of brain metastases, including the role of chemical modifiers, novel systemic agents, and the management and prevention of neurocognitive deficits.




This article has been cited by other articles:


Home page
CRO ContentHome page
G. C. Prendergast
AACR Cancer Reviews Online: A new resource for cancer researchers
Cancer Reviews Online Content, April 1, 2007; 2007(1): 1 - 2.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. B. Aragon-Ching and J. A. Zujewski
CNS Metastasis: An Old Problem in a New Guise
Clin. Cancer Res., March 15, 2007; 13(6): 1644 - 1647.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. U. Lin and E. P. Winer
Brain Metastases: The HER2 Paradigm
Clin. Cancer Res., March 15, 2007; 13(6): 1648 - 1655.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.